Evaluation of success and toxicity of autologous stem cell transplantation in patients with multiple myeloma in the geriatric age group
Open Access
- 3 August 2019
- journal article
- Published by Peertechz Publications Private Limited in Studies on Stem Cells Research and Therapy
- Vol. 5 (1), 001-006
- https://doi.org/10.17352/sscrt.000012
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patientsLeukemia, 2013
- Have drug combinations supplanted stem cell transplantation in myeloma?Blood, 2012
- International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantationBlood, 2011
- Recent major improvement in long-term survival of younger patients with multiple myelomaBlood, 2008
- Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200 mg/m2)Leukemia, 2003
- The role of autologous transplantation in patients with multiple myeloma aged 65 years and overBone Marrow Transplantation, 2000
- Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatmentBone Marrow Transplantation, 1997
- Feasibility and cost-effectiveness of outpatient autotransplants in multiple myelomaBone Marrow Transplantation, 1997
- Prognostic factors in multiple myeloma: selection using Cox's proportional hazard modelBiomedicine & Pharmacotherapy, 1996
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaThe New England Journal of Medicine, 1996